Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[(18)F]FDG PET-Negative Marrow: Results From an International Retrospective Study.
- DOI
- 10.1200/jco-25-03080
- Published
- 2026 Aug 24
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco-25-03080,
title = {Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[(18)F]FDG PET-Negative Marrow: Results From an International Retrospective Study.},
author = {Mercolini F and Just M and Shulkin BL and Collins NB and Crane J and Harrison D and Affinita MC and Allen-Rhoades W and Alessi A and Asaftei SD and Arnold MA and Chen S and Chiaravalli S and FitzGerald F and Freitag MT and Iftner JL and Khalatbari H and de Keizer B and von Luettichau I and Mauz-Körholz C and Rossig C and Rovera G and Rutkowski S and Sims JB and Voss SD and Yoshimi A and Birz S and Bisogno G and Ebinger M and Merks JHM and Sparber-Sauer M and Haller B and Weiss AR and Linardic CM and Schoot RA and Hettmer S and INSTRuCT Imaging/Pathology/Biology Network},
year = {2026},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco-25-03080},
url = {https://doi.org/10.1200/jco-25-03080}
}RIS
TY - JOUR TI - Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[(18)F]FDG PET-Negative Marrow: Results From an International Retrospective Study. AU - Mercolini F AU - Just M AU - Shulkin BL AU - Collins NB AU - Crane J AU - Harrison D AU - Affinita MC AU - Allen-Rhoades W AU - Alessi A AU - Asaftei SD AU - Arnold MA AU - Chen S AU - Chiaravalli S AU - FitzGerald F AU - Freitag MT AU - Iftner JL AU - Khalatbari H AU - de Keizer B AU - von Luettichau I AU - Mauz-Körholz C AU - Rossig C AU - Rovera G AU - Rutkowski S AU - Sims JB AU - Voss SD AU - Yoshimi A AU - Birz S AU - Bisogno G AU - Ebinger M AU - Merks JHM AU - Sparber-Sauer M AU - Haller B AU - Weiss AR AU - Linardic CM AU - Schoot RA AU - Hettmer S AU - INSTRuCT Imaging/Pathology/Biology Network PY - 2026 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco-25-03080 UR - https://doi.org/10.1200/jco-25-03080 ER -
APA
F, M., M, J., BL, S., NB, C., J, C., D, H., MC, A., W, A., A, A., SD, A., MA, A., S, C., S, C., F, F., MT, F., JL, I., H, K., B, D. K., I, V. L., C, M., C, R., G, R., S, R., JB, S., SD, V., A, Y., S, B., G, B., M, E., JHM, M., M, S., B, H., AR, W., CM, L., RA, S., S, H., & Network, I. I. (2026). Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[(18)F]FDG PET-Negative Marrow: Results From an International Retrospective Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-03080
Source records
- pubmed · retrieved 2026-09-25T13:08:13.827Z